spot_img
Wednesday, November 29, 2023

Cuatrecasas counsels Sacyr Servicios on €87m sale of Sacyr Facilities to Grupo Serveo

Cuatrecasas advised Sacyr Servicios, S.A., a subsidiary of Sacyr, S.A. (BME: SCYR), on the sale of shares representing 100% of the share capital of Sacyr Facilities, S.A.U. to Grupo Serveo, S.L., owned by Portobello Capital, for €87 million

-

Sacyr Services could additionally receive €15 million. The transaction – subject to obtaining, among others, the relevant regulatory authorisations – is expected to close in the last quarter of 2023. 

With this transaction, and following the sale of Valoriza Servicios Medioambientales, S.A. to a Morgan Stanley Infrastructure Partners fund, which was announced in June and in which Cuatrecasas also advised, Sacyr, S.A. is moving forward in achieving the objectives of its 2021-2025 Strategic Plan. The transaction allows Sacyr to reduce its net recourse debt and, in addition, to continue boosting its concession businesses.

The transaction has been led by Francisco J. Martínez Maroto, partner of the Corporate and M&A area, together with Carlota Tojo, Pedro López-Dóriga, Álvaro Lucena and Julián Ruan, of the same area. Multidisciplinary teams from our offices in Madrid, Santiago de Chile and Bogotá also participated in the advice, including Félix Plasencia, Carlos Lasarte, Julio Brasa, Soraya Sáenz de Santamaría, Fernando Bernad, Andrew Ward, Alejandro Negro, Roberto Guerrero, Macarena Ravinet and Juan Felipe Vera, among others.

- Advertisement -spot_img
- Advertisement -spot_img

MOST READ NEWS

Multi-law firm advice on Brown‑Forman´s acquisition of Gin Mare

Brown‑Forman Corporation has announced its agreement to purchase the Gin Mare brands from Vantguard and MG Destilerías. Upon completion of the transaction, Brown‑Forman will...

CC advises QuironSalud on sale of hospital in Peru

The divested portfolio consists of QuironSalud's stake in the flagship hospital Clínica Ricardo Palma located in Lima. Entities of the Verme family, who currently...

Evergreen advises Tresmares Capital on its entry into Proteos Biotech

Proteos Biotech specialises in producing recombinant enzymes whose products have high-quality standards backed by various certifications and scientific support. The company develops exclusive assets...
spot_img
spot_img
spot_img
spot_img
- Advertisement -spot_img
error: